$0.806
-0.009 (-1.16%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Pliant Therapeutics Inc (PLRX) Moving Averages Convergence Divergence (MACD) indicator is -0.05, suggesting PLRX is Strong sell.
Pliant Therapeutics Inc (PLRX) 20-Day simple moving average is 0.88, while Pliant Therapeutics Inc (PLRX) share price is $—, making it Sell.
Pliant Therapeutics Inc (PLRX) 60-Day simple moving average is 1.03, while Pliant Therapeutics Inc (PLRX) share price is $—, making it Sell.
Technical Analysis for PLRX
AI Technical PLRXAs of 2026-11-03, the technical board for Pliant Therapeutics Inc (PLRX) reads strong sell: 2 indicators are flashing buy, 9 are indicating sell, and 2 are neutral. Price at $0.81 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 31.899, MACD stands at -0.0526 (Sell), Stochastic %K stands at 12.753 (Buy), Stochastic %D stands at 13.933 and CCI stands at -127.688 (Buy).
PLRX trades below the 60-day SMA (1.03) and below the 200-day SMA (1.15). Immediate resistance sits at Classic R1 0.90, then R2 0.96. Support sits at Classic S1 0.80, then S2 0.74.
Pliant Therapeutics Inc (PLRX) Support & Resistance Level
Pliant Therapeutics Inc (PLRX) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 31.899 |
| STOCHk_14_3_3 | 12.753 |
| STOCHd_14_3_3 | 13.933 |
| CCI_20 | -127.688 |
| AO_5_34 | -0.124 |
| MOM_10 | -0.054 |
| MACD_12_26_9 | -0.053 |
Pliant Therapeutics Inc (PLRX) Relative Strength Index (RSI_14) is 31.899, creating a Neutral signal.
Pliant Therapeutics Inc (PLRX) Stochastic %K is 12.753, creating a Buy signal.
Pliant Therapeutics Inc (PLRX) Stochastic %D is 13.933, creating a Buy signal.
Pliant Therapeutics Inc (PLRX) CCI_20 is -127.688, creating a Buy signal.
Pliant Therapeutics Inc (PLRX) Awesome Oscillator (AO) is -0.124, creating a Sell signal.
Pliant Therapeutics Inc (PLRX) Momentum (MOM) is -0.054, creating a Sell signal.
Pliant Therapeutics Inc (PLRX) Moving Average Convergence Divergence (MACD) is -0.053, creating a Sell signal.
Pliant Therapeutics Inc (PLRX) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 0.835 | Sell |
| MA_10 | 0.849 | Sell |
| MA_20 | 0.881 | Sell |
| MA_60 | 1.033 | Sell |
| MA_200 | 1.150 | Sell |
| MA_250 | 1.196 | Sell |
Pliant Therapeutics Inc (PLRX) 5-Day simple moving average is 0.835, while Pliant Therapeutics Inc (PLRX) share price is $, making it a Sell.
Pliant Therapeutics Inc (PLRX) 10-Day simple moving average is 0.849, while Pliant Therapeutics Inc (PLRX) share price is $, making it a Sell.
Pliant Therapeutics Inc (PLRX) 20-Day simple moving average is 0.881, while Pliant Therapeutics Inc (PLRX) share price is $, making it a Sell.
Pliant Therapeutics Inc (PLRX) 60-Day simple moving average is 1.033, while Pliant Therapeutics Inc (PLRX) share price is $, making it a Sell.
Pliant Therapeutics Inc (PLRX) 200-Day simple moving average is 1.150, while Pliant Therapeutics Inc (PLRX) share price is $, making it a Sell.
Pliant Therapeutics Inc (PLRX) 250-Day simple moving average is 1.196, while Pliant Therapeutics Inc (PLRX) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.